8/17/2019 Kuliah 1 (Biochemical_Engineering )
1/46
Biochemical Engineering
Dr. Amyl Ghanem
Department of Chemical Engineering
Dalhousie University
8/17/2019 Kuliah 1 (Biochemical_Engineering )
2/46
Outline
• What is biochemical engineering?
• The catalysts
•Relationship to engineering• Historical perspective: penicillin
• The industry: facts
• The industry:• Food, beer and wine• ndustrial chemicals
• !harmaceuticals
8/17/2019 Kuliah 1 (Biochemical_Engineering )
3/46
Some definitions….
• "iotechnology: use or development of methods of direct geneticmanipulation for a socially desirable goal# $ometimes a broaderdefinition is used, where biotechnology is applied iology #
• "iomedical %ngineering: engineering on systems to improve human
health
• "ioengineering, biological engineering: wor& on medical oragricultural systems, draws on electrical, mechanical, industrial andchemical engineers#
• Biochemical Engineering! e"tension of chemical engineering principles to systems using a iocatalyst to ring aout desiredchemical transformation#
8/17/2019 Kuliah 1 (Biochemical_Engineering )
4/46
#he story of penicillin
'le(ander Fleming)s photo of the dish withbacteria and !enicillin mold, *+-
8/17/2019 Kuliah 1 (Biochemical_Engineering )
5/46
8/17/2019 Kuliah 1 (Biochemical_Engineering )
6/46
#he story of penicillin
*+- *+./0s
1iscovered by 'le(ander Fleming
2hemical synthesisproved to be too difficult
Fermentationroute was chosen
%fforts to increase production•cell line selection•medium optimi3ation
•process development
Full scale production
15+ years
8/17/2019 Kuliah 1 (Biochemical_Engineering )
7/46
Biocatalyst! cells and en$ymes
*/4/ µm *45 µm
8/17/2019 Kuliah 1 (Biochemical_Engineering )
8/46
%n3yme: 'cetylcholinesterasesi3e range in nm
E + S E-S E + P
8/17/2019 Kuliah 1 (Biochemical_Engineering )
9/46
#ypical chemical processing
'
"
'6" !
! '"
temperatureflowrate
'
!
"
Reactor $eparation
8/17/2019 Kuliah 1 (Biochemical_Engineering )
10/46
Cell as a ioreactor
!roduct :
cellssmall moleculeen3yme '
!21 etc#
?
Reactor inside a reactor $eparation
reactor
'
!
cell
"21
% !
'
8/17/2019 Kuliah 1 (Biochemical_Engineering )
11/46
Bioprocesses are %special&…….
• 2ells are living organisms that re7uire specific conditionsfor growth, production
• 2ells grow in culture medium 8nutrients9 that may
support other cell types 8contamination9• "ioproducts are often sensitive to e(ternal conditions 8T,
pH9 and can easily be destroyed 8separations9
• !roduct is generally very dilute in bioreactor medium
• any byproducts in medium to remove
8/17/2019 Kuliah 1 (Biochemical_Engineering )
12/46
….ut they have their advantages'
• 2ells will often perform reactions that are too difficult todo synthetically 8penicillin9
• 2ells can turn basic nutrients 8for e(ample, agricultural
waste9 into valuable products• 'ma3ing diversity of products from cells
• 2ells can be modified to increase product diversity evenmore;
• %n3ymes are highly specific catalysts with high catalyticpower
8/17/2019 Kuliah 1 (Biochemical_Engineering )
13/46
IndustryB.Sc. M.S. Ph.D.
/// *++* /// *++* /// *++*
2hemical #= .#* >-#* -#. .<
Fuels *#< *# -#5 *
%lectronics *5#< #. #- ># *+ .#-Food2onsumer !roducts **#. =# .#5 .#5 #- 5#<
aterials >#> #= =#* 5#- ># /#+ /#-
%ngineering $ervices +#- -# */#= *.#+
"usiness $ervices and
@therA
**#
8/17/2019 Kuliah 1 (Biochemical_Engineering )
14/46
)ndustry in Canada! Biotechnology
• >5- "iotech companies in 2anada in *+++
• B*#+ billion in revenue
• =
8/17/2019 Kuliah 1 (Biochemical_Engineering )
15/46
)ndustry in Canada! Bioproducts
Firms that produce fuels, chemicals, materials andspecialty products using biological feedstoc&s andbioprocessese". alcohol from agricultural and forest feedstoc*+ en$yme
production companies
•=54*// companies that underta&e RD1 andmanufacturing
•B*//4*5/ million in sales each year •*5//4/// people employed•Eery young industry;;
8/17/2019 Kuliah 1 (Biochemical_Engineering )
16/46
)ndustry in Canada! ,edical Devices
• -// manufacturing firms in /// 8+/C2anadian4owned9
• >#* billion in revenue, *#< billion of which
were e(ports• *-,/// people employed
• e(9 cardiovascular devices and treatments
such as heart valves and %2 systems• in vitro diagnosticsG imagingG dental
implants and materials
8/17/2019 Kuliah 1 (Biochemical_Engineering )
17/46
)ndustry in Canada! Chemicals
• n ///, there were *,// establishmentsoperating in 2anada#
• They employed appro(imately =,5//employees#
• 2anadian shipments in /// were valuedat B>/# billion
8/17/2019 Kuliah 1 (Biochemical_Engineering )
18/46
)ndustry -ocus! -ood and everage
8/17/2019 Kuliah 1 (Biochemical_Engineering )
19/46
)ndustry -ocus! -ood and everage
Fermentation !roducts
• cheese
• soy products• yoghourt• wine, beer • bread
%n3ymes
• adust food flavour
• adust food te(ture• improve nutritional
7uality
• high fructose cornsyrup
8/17/2019 Kuliah 1 (Biochemical_Engineering )
20/46
-ermentation
• ' form of anaerobic respiration occurring in certainmicroorganisms 8e(# yeasts9
• 'lcoholic fermentation is a series of biochemicalreactions by which pyruvate is converted to ethanol and
2@,#
8/17/2019 Kuliah 1 (Biochemical_Engineering )
21/46
Metabolic pathways in e.coli
8/17/2019 Kuliah 1 (Biochemical_Engineering )
22/46
C / 01 O 2 1 C 1 / 3 O/ 4 1 CO1
• 2ommon yeast saccharomyces cerevisae used in ma&ing wine,
beer, bread by above reaction#• 1ifferent strains of yeast can tolerate different alcohol
concentrations#• Theoretically, *-/ g of sugar will produce + g of ethanol
'ctual yield is only -.#< g of ethanol
∀ ρ%t@H 8/°29 I /#=-+ gmJ
• volume of ethanol I -.#< g ( mJ I */=# mJ /#=-+ g
• volume of the alcohol and water contracts by /#=C so*/=# mJ ( *#//= I */- mJ for an overall alcohol
concentration of */#-C 8vv:*/-*///9#
8/17/2019 Kuliah 1 (Biochemical_Engineering )
23/46
8/17/2019 Kuliah 1 (Biochemical_Engineering )
24/46
• "ri( 8"/9 is a density measurement that indicates thepercentage of sugar in *// g of a sugar4water solution#"ri( can be calculated by:
• "ri( I Kg sugar8g sugar 6 g water9L ( *//
• "ri( units can be used to predict the alcohol content inwine#
• C potential alcohol 8vv9 I /#5= ( "ri(initial
8/17/2019 Kuliah 1 (Biochemical_Engineering )
25/46
Beer ma*ing
• alting: grains 8barley, rice9 are steeped in water untilgermination and then dried before a plant develops# The starches inthe grains get converted to sugars by en3ymes#
• "rewing: finely ground malt is turned into a sweetened li7uidby adding warm water added and heating to around =5o where thesugars get dissolved# rain is filtered out, and its boiled forsterili3ation and concentration 8wort9
• Fermentation: the yeast turns the sugar in the wort intoalcohol, a process that ta&es about */ days#
8/17/2019 Kuliah 1 (Biochemical_Engineering )
26/46
5ine ma*ing
8*9 Meast !roliferation 4 aerobico(ygen is needed to sterol productionincreased yeast robustness
89 nitial Fermentation 4 anaerobicsugar is converted to alcoholduration times typically 5 4 * days
8>9 $econdary Fermentation 4 malolacticlactic bacteria metaboli3e malic acid to lactic acidlowered acidity and wine NsofteningO occursvery typical for red wines
8/17/2019 Kuliah 1 (Biochemical_Engineering )
27/46
6rocess flo7sheet for 7ine
8/17/2019 Kuliah 1 (Biochemical_Engineering )
28/46
-actors affecting yeast fermentation
• Meast $pecies
• Temperature
• $ugar concentration• pH
• Eitamins
• $ulfur dio(ide 8$@,9
8/17/2019 Kuliah 1 (Biochemical_Engineering )
29/46
)ndustry -ocus! #e"tiles
8/17/2019 Kuliah 1 (Biochemical_Engineering )
30/46
Stone 7ashing denim
1enim is faded byabrasive action ofpumice stones
ndigo dye adheresto denim surface
2ellulase en3ymeremoves some of the dyeby partially hydroly3ing thecotton surface
•new loo&s•lower costs•shorter treatment times•less solid waste
•wea&ens the fabric
traditional
method ne7 method
8/17/2019 Kuliah 1 (Biochemical_Engineering )
31/46
Detergents
• 1etergent industry is the largest single mar&et for en3ymesat 5 4 >/C of total sales
• 1irt comes in many forms and includes proteins, starchesand lipids 8fats and oils9
• proteases, amylases, lipases are en3ymes used indetergents
• en3ymes allows lower temperatures and less agitation forwashing
Inner core of enzyme plus
preservative bound ith !"!
#rotective a$y coat that
disperses in the ash
8/17/2019 Kuliah 1 (Biochemical_Engineering )
32/46
)ndustrial Chemicals
%(amples:
• organic acids produced from Aspergillusniger , citric acid used in soft drin&s
• Pylanase used for wood pulping andbleaching
8/17/2019 Kuliah 1 (Biochemical_Engineering )
33/46
Agricultural
%(amples:
• Recombinant bovine somatotropin 8b$T9for increasing mil& production
• "io4insecticides for crop protection
• !hyto4vanilla8tm9 flavor derived from
tissue culture
8/17/2019 Kuliah 1 (Biochemical_Engineering )
34/46
Environment
• 2leanup of ha3ardous waste sites usingbacteria that feed on pollutants
• "acteria used for bio4remediation
• wastewater treatment• "iosensors: use biological activity to
detect to(ic substances
• R$Q Water tests: antibody based &it todetect low level of solvents such asben3ene
8/17/2019 Kuliah 1 (Biochemical_Engineering )
35/46
-uel ethanol
8/17/2019 Kuliah 1 (Biochemical_Engineering )
36/46
)ndustry -ocus! 6harmaceuticals
8/17/2019 Kuliah 1 (Biochemical_Engineering )
37/46
Phase II clinical trialsin 100 to 300 patients
The Drug Development and Approval ProcessThe drug discovery and approval process takes and average of
15 years and costs almost $00 millionsource! Pharmaceutical "esearch and #anufacturers of America %ashington D& 1''(
Discovery ofa promisingcompound
Preclinical testingin animals
Phase III clinical trialsin 1000 to 3000 patients
)DA revie* andapproval
Drug may +e prescri+ed +y physicians
1 year
3 years 1' months
(,5 years - years
Phase I clinical trialsin healthy volunteers
8/17/2019 Kuliah 1 (Biochemical_Engineering )
38/46
6roducts
• $mall molecules and metabolites
• antibiotics
• !rotein drugs
• Eaccines• 'ntibodies, onoclonal antibodies 8'b9
%o& Recombinant 1' technology means bacteria andyeast can produce human proteins li&e insulin
8/17/2019 Kuliah 1 (Biochemical_Engineering )
39/46
6enicillin fermentation
8/17/2019 Kuliah 1 (Biochemical_Engineering )
40/46
1883 5orld mar*et for iopharmaceuticals
%nbrel Rheumatoid arthritisand psoriasis
'mgenWyeth B>,,*5. S$
milRemicade Rheumatoid arthritis
and 2rohn0s diseaseohnsonDohnson2entocor $chering !lough
B ,5>5 S$mil
8/17/2019 Kuliah 1 (Biochemical_Engineering )
41/46
%pogen $timulation of red bloodcells for treatment ofanemia associated withchronic renal failure
'mgen B ,.55 S$mil
eulasta $timulation ofproduction of whiteblood cells for protection
against chemotherapycomplications
'mgen B ,-- S$mil
eoRecor mon%pogin
$timulation of red bloodcells
enentechRoche2hugai B *,=*/ S$mil
Herceptin "reast cancer enentechRoche B *,
8/17/2019 Kuliah 1 (Biochemical_Engineering )
42/46
,onoclonal antiodies
8/17/2019 Kuliah 1 (Biochemical_Engineering )
43/46
8/17/2019 Kuliah 1 (Biochemical_Engineering )
44/46
9e7 challenges….
ncreasingly, bacteriaand yeast cannotcorrectly form the
human protein:
animal cell culture
e": mouse cellsre;uire even more
careful treatment Large quantities
8/17/2019 Kuliah 1 (Biochemical_Engineering )
45/46
Opportunities for you<
The "ioproducts industry Nneeds staff thatbridge the &ey disciplines of biology,
chemistry and engineeringO
2anada0s nnovation $trategy , //*overnment of 2anada"ioproducts $ector !rofile
8/17/2019 Kuliah 1 (Biochemical_Engineering )
46/46
,ain )ssues
• Types of reactors to provide high o(ygen transfer
• 'ppropriate cell and medium selection
• $terili3ation and maintaining sterility, no crosscontamination
• n pharma, product purity and 7uality impedes processchange
• 2ells and molecules are sensitive to e(treme conditions
• rowth rate and reaction rates are small
• !roduct is usually very dilute• on traditional methods of separation
• @ften batch operations